South Korea hosts the largest number of UC-focused stem cell clinics, with variable credentialing. Turkey and parts of Eastern Europe offer treatment at lower cost but with differing regulatory oversight. Spain, Germany, and the Netherlands conduct formal research trials, offering greater transparency but limited public access. The US restricts uncontrolled private clinics for UC but maintains academic research pathways. Clinic selection should prioritise published outcomes and regulatory status.
UC-targeted stem cell infusions are offered in South Korea, Turkey, and select European centres at costs ranging from €3,500–€8,000 per course. UK private clinics are sparse; overseas treatment requires travel. Standard UC pharmacotherapy (biologic agents like infliximab or vedolizumab) costs £3,000–£10,000 annually through private UK insurers, though NHS provides these at no out-of-pocket cost for eligible patients. Stem cell therapy's cost-benefit remains unfavourable in healthcare systems where biologics are accessible, though individual circumstances vary. Out-of-pocket stem cell expenditure may exceed annual pharmaceutical costs within a single treatment cycle.
האם אני מועמד? → · Ulcerative Colitis: full overview → · עלות קוליטיס אולצרטיבית → · Cost →
בדוקה רפואית על ידי צוות העריכה של StemCellAtlas עם Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) של קליניקת השותף Stem Plus (סופיה), כנגד הנחיות ISSCR, FDA ו-EMA. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם